Pyxis Oncology, Inc.
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targ…
Biotechnology
US, Cambridge [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Pyxis Oncology, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPyxis Oncology, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Pyxis Oncology, Inc..
If you want to see a demo, head over to the financial segments of AAPL